首页 | 本学科首页   官方微博 | 高级检索  
检索        

美罗华联合CHOP治疗B细胞性非霍奇金淋巴瘤的临床研究
引用本文:黄小兵,符成杰,刘骅,余晓峰.美罗华联合CHOP治疗B细胞性非霍奇金淋巴瘤的临床研究[J].白求恩军医学院学报,2009,7(5):288-289.
作者姓名:黄小兵  符成杰  刘骅  余晓峰
作者单位:江苏省东台市中医院肿瘤科,东台,224200
摘    要:目的评价美罗华(Rituximab)联合CHOP(R-CHOP)治疗CD20阳性B细胞性非霍奇金淋巴瘤(NHL)的临床疗效及不良反应。方法采用同期非随机对照的前瞻性研究方法,将62例初治B细胞淋巴瘤患者分为R-CHOP组和CHOP组。其中,R-CHOP组34例,采用R-CHOP方案化疗;CHOP组28例,采用CHOP方案化疗。6个疗程后比较两组的临床疗效及不良反应。结果R-CHOP组完全缓解率79.4%(27/34),总有效率91.2%(31/34);CHOP组完全缓解率57.1%(16/28),总有效率71.4%(20/28),两组临床疗效差异有统计学意义(P〈0.05)。两组不良反应差异无统计学意义(P〉0.05)。结论R-CHOP方案治疗CD20阳性B细胞性非霍奇金淋巴瘤疗效更好,且未增加不良反应。

关 键 词:美罗华  非霍奇金淋巴瘤  治疗  CHOP

The clinical study of CHOP combined with Rituximab in treating B-cell non-Hodgkin lymphoma
HUANG Xiaobing,FU Chengjie,LIU Hua,et al..The clinical study of CHOP combined with Rituximab in treating B-cell non-Hodgkin lymphoma[J].Journal of Bethune Military Medical College,2009,7(5):288-289.
Authors:HUANG Xiaobing  FU Chengjie  LIU Hua  
Institution:HUANG Xiaobing,FU Chengjie,LIU Hua,et al.Department of Oncology,Dongtai Traditional Chinese Medicine Hospital,Dongtai 224200,China
Abstract:Objective To evaluate the efficacy and side-effects of CHOP combined with Rituximab(R-CHOP) in treating CD 20 positive B-cell non-Hodgkin lymphoma(NHL).Methods Applying the prospective study method with non-random and concurrent control,62 newly diagnosed patients with B-cell NHL were divided into two groups,R-CHOP group and CHOP group.34 cases in R-CHOP group were treated with R-CHOP while 28 cases in CHOP group were treated with CHOP.The efficacy and side-effects of these two groups were evaluated after 6...
Keywords:CHOP
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号